OVERWEIGHT PATIENTS

THE IMPORTANCE OF OSA IDENTIFICATION IN THE BARIATRIC PATIENT

If you look for OSA, you will find it. An estimated 2 to 4 percent of the adult population is said to suffer from symptomatic OSA, and asymptomatic cases (no report of sleepiness) among middle-aged populations are as prevalent as nine percent in women and 24 percent in men.7 Given the increasing rates of obesity (a major risk factor for OSA) in the US, we are likely to see that more and more surgical patients will have OSA, the vast majority undiagnosed. It is important to identify OSA in the surgical patient because it can lead to a plan that can minimize perioperative complications associated with the disorder. First, the airway is the obvious anesthetic concern in patients with OSA. Studies confirm an increased risk of difficult intubation, and excess pharyngeal tissue may lead to difficulties with mask ventilation. More recent data have demonstrated that OSA patients are at risk for major cardiovascular morbidity and mortality, which may certainly impact the perioperative course. Hypertension is common among OSA patients and appears to be related to repeated increased sympathetic tone secondary to oxyhemoglobin desaturation and frequent nocturnal arousals. The increased sympathetic activity surrounding the apneic episodes may also contribute to a documented increase in sudden death at night, more early morning acute coronary events, and an increase in arrhythmias. OSA I an independent risk factor for coronary artery disease, and the hazard ratio for stroke or death is nearly double the normal population, even after adjustment for comorbidities.

THERAPEUTIC OPTIONS FOR OSA

Therapeutic options for OSA include continuous positive airway pressure (CPAP) and related devices, such as bilevel positive airway pressure (BiPAP), oral appliances, or surgery. CPAP is more effective at improving OSA when compared to oral appliances, but may not be different subjectively. The most commonly used oral appliances act by advancing the mandible in order to increase the patency of the upper airway. Oral appliances are probably best suited for patients with mild OSA or those who cannot tolerate CPAP.

IMPORTANCE OF PREOPERATIVE TREATMENT AND SCREENING

Given the perioperative risks associated with OSA, it is important to diagnose and treat OSA preoperatively. Although no studies definitively demonstrate that diagnosing and treating OSA leads to improved surgical outcomes, studies do show that the lack of diagnosis and treatment leads to worse postoperative surgical outcomes. Given the positive systemic changes that occur with successful treatment of OSA, such as improvement in hypertension and nocturnal oxyhemoglobin saturation levels, it appears that CPAP therapy should be initiated as early as possible. Do patients with suspected sleep apnea need to undergo PSG testing, the gold standard for diagnosis of OSA? Given the time and expense involved in such testing and the potential number of patients involved, PSG testing may be more appropriately reserved for those suspected to have OSA. For that subset of patients, an HST sleep study will also allow initiation of therapy, such as CPAP, prior to surgery. The use of newer home-diagnostic HST equipment offers an attractive alternative to traditional laboratory PSG (by both reducing cost and increasing patient comfort), but valid means to conduct such studies do not yet exist.

PERIOPERATIVE CONCERNS: ANESTHESIA

Establishing a diagnosis of OSA in the surgical patient may lead to changes in the anesthetic plan. Nearly all centrally acting anesthetic drugs reduce oropharyngeal tone, increasing the possibility of airway obstruction. Similarly, postoperative use of narcotics or benzodiazepines reduces upper-airway tone, thereby unmasking or worsening sleep apnea. OSA patients may be sensitive to even small doses of these medications. Consequently, deep sedation may not be an option, making general anesthesia with a secured airway the safer choice. End-tidal carbon dioxide monitoring should be used during sedation to help monitor for obstruction. Placing the patient in the classic “sniffing” position has also been shown to help maintain a patent airway. If alternatives to sedation or general anesthesia exist for a particular procedure, such as a regional nerve block, this option should be considered. If general anesthesia is planned, close attention must be given to the possibility of difficult intubation, with assistance and airway adjuncts readily available. Patients should be extubated only when fully awake, with their head elevated, and neuromuscular blocking agents fully reversed. Oxygen should be administered by mask after extubation, although this might prolong the period before apnea is recognized by a drop in oxygen saturation. Non-opioid analgesics, such as non-steroidal anti-inflammatory agents or ketorolac, and analgesic adjuncts such as local anesthetics should be used whenever possible. The goal is to reduce the need for opioids, and consequently the risk of respiratory depression and airway obstruction.

POSTOPERATIVE MONITORING

The little consensus appears in the literature regarding postoperative monitoring of the OSA patient. The ASA guidelines recommend continuous pulse oximetry monitoring until such time that the patient maintains a room air oxygen saturation of 90 percent during sleep. If the patient uses CPAP or another OSA therapy at home, this should be reinitiated as soon as feasible, and with the patient’s own equipment, if possible. For patients undergoing ambulatory surgery, the ASA guidelines are cautious. They recommend that an OSA patient be monitored about three hours longer than a patient without OSA. Furthermore, if airway obstruction or hypoxemia occurs during recovery, they recommend that the patient be monitored for seven hours after the last episode while breathing room air undisturbed. This obviously makes any ambulatory surgery beyond minor peripheral or superficial procedures a near impossibility, especially if the patient requires a general anesthetic. But the ASA closed-claims database seems to support this aggressive treatment approach. After the introduction of the ASA difficult airway management guidelines in 1993, there has been a significant drop in death and brain damage suits due to airway management at induction. However, there has been no change during other phases of anesthetic care, including extubation and recovery. If this post-anesthetic phase is perilous for the general population, it can only be more so for the OSA patient. A retrospective study from the Mayo clinic was, in fact, able to show more serious postoperative complications, unplanned ICU transfers, and longer hospital stays in OSA patients undergoing joint replacements compared to non-OSA case controls

CONCLUSION

If not diagnosed or suspected, OSA may place the patient at unnecessary risk postoperatively. Less experienced providers may increase the frequency of administration or the dose of narcotics in an effort to make the patient more comfortable. In the patient with OSA, the result may by respiratory compromise leading to respiratory arrest. In a patient with a difficult airway, or in an offsite location such as radiology, the consequences can be grave. An appreciation of the seriousness of OSA, knowledge of best practices, and team focus on patient safety helps avoid adverse outcomes.OSA is a highly prevalent, frequently undiagnosed, and clinically meaningful medical condition that is particularly perturbed in the perioperative period and can lead to worse surgical outcomes if not recognized and treated. One can screen for possible OSA by employing brief screening tools and conducting focused physical examinations (both outlined in this article) that, if positive, should prompt polysomnography for definitive diagnosis and treatment where possible. The perioperative implications include the need for diagnosis and treatment of previously undiagnosed individuals, airway management, pain control issues, and postoperative monitoring needs. Surgeons, anesthesiologists, and nurses providing care to this patient population need to be fully aware of the risks involved and plan accordingly.

REFERENCES

1. O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004;14:23–6.
2. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19):1378–84.
3. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl JMed 2005;353(19):2034–41.
4. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352(12):1206–14.
5. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14(6):540–5.
6. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131(7):485–91.
7. Young T, Palta M, Dempsey J, Skatrud J, et al. The occurrence of sleep-disordered breathing among middleaged adults. N Engl J Med 1993;328(17):1230–35.
8. Siyam MA, Benhamou D. Difficult endotracheal intubation in patients with sleep apnea syndrome. Anesth Analg 2002;95:1098–102.
9. Lattimore JDL, Celemajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003;41:1429–37.
10. Kobayashi K, Nishimura Y, Shimada T, et al. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome.Chest 2006;129:632–7.
11. Giles TL, Lasserson TJ, Smith BJ, et al. Continuous positive airways pressure for obstruction sleep apnea in adults. Cochrane Database Syst Rev 2006;(1):CD001106.
12. Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnea. Cochrane Database Syst Rev 2006;(1):CD004435.
13. Sundaram S, Bridgman SA, Lim J, Lasserson TJ. Surgery for obstructive sleep apnea. Cochrane Database Syst Rev 2005;(4):CD001004.
14. Huerta S, DeShields S, Shpiner M, Safety & efficacy of postoperative CPAP to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002;6:354–8.
15. Gupta RM, Parvizi J, Hanssen AD, Gay PC. Postoperative complications in patients with osa syndrome undergoing hip or knee replacement: A casecontrol study. Mayo Clin Proc 2001;76(9):897–905.
16. ASA practice guidelines for the perioperative management of patients with obstructive sleep apnea. Anesthesiology 2006;104:1081–93.
17. Hillman DR, Platt PR, Eastwood PR. The upper airway during anesthesia. Br J Anaesth 2003;91:31–9.
18. Isono S, Atsuko T, Ishikawa T, et al. Sniffing position improves pharyngeal airway patency in anesthetized patients with obstructive sleep apnea. Anesthesiology 2005;103:489–94.
19. Schumann R, Jones SB, Ortiz VE, et al. Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery. Obes Research 2005;13:254–66.
20. Benumof JL. Obstructive sleep apnea in the adult obese patient: Implications for airway management. Anesthesiol Clin North America 2002;20:789–811.
21. Peterson GN, Domino KB, Caplan RA, et al. Management of the difficult airway: A closed claims analysis. Anesthesiology 2005;103:33–9..